Winston Medical Supply Co., Ltd. (TPEX:6817)
Taiwan · Delayed Price · Currency is TWD 50.80
-1.20 (-2.31%)
Jul 30, 2026, 1:09 PM CST
Winston Medical Supply Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 117.29 | 131.59 | 158.76 | 111.26 | 92.13 |
Depreciation & Amortization | 25.94 | 28.96 | 27.47 | 35.51 | 35.32 |
Other Amortization | 0.86 | 0.68 | 0.51 | 0.79 | 0.81 |
Loss (Gain) From Sale of Assets | 0.47 | 1.11 | 1.03 | - | 0.25 |
Provision & Write-off of Bad Debts | 0.01 | -0 | -0.01 | -1.31 | 1.18 |
Other Operating Activities | -0.32 | -11.65 | 2.5 | 11.79 | 24.17 |
Change in Accounts Receivable | 18.22 | -17.2 | 2.68 | 7.45 | -12.76 |
Change in Inventory | -1.51 | -33.72 | -19.31 | 10.25 | 1.39 |
Change in Accounts Payable | -17.97 | 11.01 | 8.02 | 8.46 | 3.81 |
Change in Unearned Revenue | 19.38 | 10.23 | -0.26 | -1.83 | -6.32 |
Change in Other Net Operating Assets | -7.42 | 27.06 | 34.06 | -57.47 | 6.5 |
Operating Cash Flow | 154.97 | 148.09 | 215.45 | 124.88 | 146.46 |
Operating Cash Flow Growth | 4.65% | -31.27% | 72.52% | -14.73% | 31.06% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -16.49 | -17.85 | -19.04 | -6.39 | -5.05 |
Sale (Purchase) of Intangibles | -0.78 | -1.42 | -1.01 | -0.16 | -0.08 |
Other Investing Activities | -0.87 | 1.01 | 0.16 | -2.07 | -0.96 |
Investing Cash Flow | -18.13 | -18.26 | -19.88 | -8.62 | -6.1 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Repaid | - | - | - | - | -65 |
Long-Term Debt Repaid | -7.9 | -7.86 | -7.01 | -6.04 | -10.57 |
Total Debt Repaid | -7.9 | -7.86 | -7.01 | -6.04 | -75.57 |
Net Debt Issued (Repaid) | -7.9 | -7.86 | -7.01 | -6.04 | -75.57 |
Issuance of Common Stock | - | - | - | - | 5 |
Common Dividends Paid | -128.92 | -121.55 | -92.09 | -73.67 | -55.25 |
Other Financing Activities | -0.66 | - | - | 3.31 | 1.92 |
Financing Cash Flow | -137.48 | -129.41 | -99.1 | -76.39 | -123.9 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -0.63 | 0.41 | 96.47 | 39.87 | 16.46 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 138.49 | 130.24 | 196.41 | 118.49 | 141.4 |
Free Cash Flow Growth | 6.33% | -33.69% | 65.76% | -16.20% | 29.92% |
Free Cash Flow Margin | 19.78% | 18.74% | 27.70% | 19.54% | 26.36% |
Free Cash Flow Per Share | 7.49 | 7.04 | 10.62 | 6.41 | 7.67 |
Levered Free Cash Flow | 111.05 | 97.36 | 158.05 | 92.98 | 107.11 |
Unlevered Free Cash Flow | 111.79 | 98.09 | 159.01 | 93.64 | 108.25 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1.19 | 1.17 | 1.53 | 1.06 | 1.84 |
Cash Income Tax Paid | 29.16 | 44.23 | 37.56 | 18.35 | 0.29 |
Change in Working Capital | 10.72 | -2.61 | 25.19 | -33.15 | -7.39 |